Hookipa Pharma Inc(HOOK),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

HOOK Hookipa Pharma Inc

Market Closed 11-01 16:00:00 EDT

3.84

+0.05

+1.32%

盘后3.75

-0.09-2.34%

19:24 EDT

High4.00	Low3.76	Vol38.30K
Open3.87	D1 Closing3.79	Amplitude6.28%
Mkt Cap38.00M	Tradable Cap18.40M	Total Shares9.90M
T/O148.01K	T/O Rate0.80%	Tradable Shares4.79M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"HOOK","market":"US","secType":"STK","nameCN":"Hookipa Pharma Inc","latestPrice":3.84,"timestamp":1730491200000,"preClose":3.79,"halted":0,"volume":38302,"hourTrading":{"tag":"盘后","latestPrice":3.75,"preClose":3.84,"latestTime":"19:24 EDT","volume":138,"amount":522.22,"timestamp":1730503492009},"delay":0,"floatShares":4791000,"shares":9895000,"eps":-4.109244,"marketStatus":"Market Closed","change":0.05,"latestTime":"11-01 16:00:00 EDT","open":3.87,"high":4,"low":3.7619,"amount":148008.9746146,"amplitude":0.062823,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-4.109244,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1730710800000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1555560000000,"exchange":"NASDAQ","adjPreClose":3.79,"postHourTrading":{"tag":"盘后","latestPrice":3.75,"preClose":3.84,"latestTime":"19:24 EDT","volume":138,"amount":522.22,"timestamp":1730503492009},"volumeRatio":0.7633180212100891,"impliedVol":1.12,"impliedVolPercentile":0.2948},"requestUrl":"/m/hq/s/HOOK","defaultTab":"news","newsList":[{"id":"2479258082","title":"HOOKIPA Pharma to Present Eseba-vec Combo in Frontline HNSCC as a Late-Breaker Poster Presentation at SITC 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2479258082","media":"GlobeNewswire","labels":["Product Release"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479258082?lang=en_us&edition=fundamental","pubTime":"2024-10-31 21:17","pubTimestamp":1730380620,"startTime":"0","endTime":"0","summary":"Society of Immunotherapy of Cancer (SITC) poster to be presented by collaborator from Memorial Sloan Kettering Cancer Center, Dr. Alan Ho, on November 9, 2024NEW YORK and VIENNA, Oct.  31, 2024  (GLOB","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/10/31/2972726/0/en/HOOKIPA-Pharma-to-Present-Eseba-vec-Combo-in-Frontline-HNSCC-as-a-Late-Breaker-Poster-Presentation-at-SITC-2024.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Product Release","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01308","SITC","IE00BYTNYN87.SGD","BK1103","SG9999011746.SGD","IE00BYQNZ168.SGD","BK1541","HOOK","IE00B12V2V27.USD","BK4139","BK4505","BK4080","BK4231"],"gpt_icon":1},{"id":"2479205240","title":"BRIEF-HOOKIPA Pharma Doses First Patients With ESEBA-VEC As Adjuvant Therapy In Phase 2 Investigator Lead Trial For Head & Neck Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2479205240","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479205240?lang=en_us&edition=fundamental","pubTime":"2024-10-30 19:44","pubTimestamp":1730288688,"startTime":"0","endTime":"0","summary":"Oct 30  - HOOKIPA Pharma Inc   :   * HOOKIPA PHARMA DOSES FIRST PATIENTS WITH ESEBA-VEC AS ADJUVANT THERAPY IN PHASE 2 INVESTIGATOR LEAD TRIAL FOR HEAD & NECK CANCER   * HOOKIPA PHARMA INC - INITIAL SAFETY AND EFFICACY DATA FROM IIT EXPECTED IN 2026Source text:    Further company coverage:    ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HOOK","BK4139","BK4505"],"gpt_icon":0},{"id":"2479975203","title":"HOOKIPA Pharma Doses First Patients With Eseba-Vec as Adjuvant Therapy in Phase 2 Investigator Lead Trial for Head & Neck Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2479975203","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479975203?lang=en_us&edition=fundamental","pubTime":"2024-10-30 19:30","pubTimestamp":1730287800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241030:nTUA3GYCSC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","HOOK","BK4505"],"gpt_icon":0},{"id":"2479203995","title":"HOOKIPA Pharma Inc - Initial Safety and Efficacy Data From Iit Expected in 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2479203995","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479203995?lang=en_us&edition=fundamental","pubTime":"2024-10-30 19:30","pubTimestamp":1730287800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241030:nTUA3GYCSC:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HOOK","BK4505","BK4139"],"gpt_icon":0},{"id":"2479030042","title":"HOOKIPA Pharma Doses First Patients with Eseba-vec as Adjuvant Therapy in Phase 2 Investigator Lead Trial for Head & Neck Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2479030042","media":"GlobeNewswire","labels":["Product Release"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479030042?lang=en_us&edition=fundamental","pubTime":"2024-10-30 19:30","pubTimestamp":1730287800,"startTime":"0","endTime":"0","summary":"Study done in collaboration with Memorial Sloan Kettering and led by Dr. Winston Wong, Head and Neck Oncologist and Dr. Alan Ho, Chief of the Head and Neck Oncology Service IIT will evaluate eseba-vec","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/10/30/2971586/0/en/HOOKIPA-Pharma-Doses-First-Patients-with-Eseba-vec-as-Adjuvant-Therapy-in-Phase-2-Investigator-Lead-Trial-for-Head-Neck-Cancer.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Product Release","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","HOOK","BK4505"],"gpt_icon":1},{"id":"2471673398","title":"Watch Out: Big Token Unlock Wave Coming at the End of the Month – 19 Altcoins Have Massive Token Unlocks – Here’s a Day-by-Day, Hour-by-Hour...","url":"https://stock-news.laohu8.com/highlight/detail?id=2471673398","media":"CoinMarketCap","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2471673398?lang=en_us&edition=fundamental","pubTime":"2024-09-30 04:39","pubTimestamp":1727642363,"startTime":"0","endTime":"0","summary":"The cryptocurrency market showed an overall rise after Bitcoin broke through the psychological $66,000 mark for the first time in a long time.However, the rise did not continue and there was a wave of decline over the weekend, especially in altcoins.Related News: Unusual Trading Volume Spikes Detected in 5 Altcoins in South Korea - Here's the List","market":"us","thumbnail":"https://academy-public.coinmarketcap.com/srd-optimized-uploads/8f0a954ca9bc4c5db8b85e347575d9c5.webp","type":0,"news_type":0,"thumbnails":["https://academy-public.coinmarketcap.com/srd-optimized-uploads/8f0a954ca9bc4c5db8b85e347575d9c5.webp"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://coinmarketcap.com/community/articles/66f9bafb8c042a5e40d3c056/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"coinmarketcap_highlight","symbols":["BK4129","LU1721429402.USD","OP","OP.USD.HKCC","BK4504","BK4021","BK4588","LU1585245621.USD","DG","BK4135","HOOK","BK4155","LU1721429741.USD","BK4179","LU2211817866.USD","SLND","BK4585","BK4114","BK4189","BK4139","STEP","DAR","GAL","LU1430594728.SGD","LU2308191902.HKD","SEI","LU1989763690.USD","LU2380233275.USD","BK4505","LU1989763427.SGD"],"gpt_icon":0},{"id":"2470019257","title":"HOOKIPA Pharma Inc.'s (NASDAQ:HOOK) 26% Dip In Price Shows Sentiment Is Matching Revenues","url":"https://stock-news.laohu8.com/highlight/detail?id=2470019257","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2470019257?lang=en_us&edition=fundamental","pubTime":"2024-09-27 18:39","pubTimestamp":1727433578,"startTime":"0","endTime":"0","summary":"HOOKIPA Pharma Inc. ( NASDAQ:HOOK ) shareholders that were waiting for something to happen have been dealt a blow with...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-hook/hookipa-pharma/news/hookipa-pharma-incs-nasdaqhook-26-dip-in-price-shows-sentime","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["NDAQ","HOOK",".IXIC"],"gpt_icon":0},{"id":"2469462318","title":"HOOKIPA Pharma to Present Strong Preclinical HB-700 Dataset","url":"https://stock-news.laohu8.com/highlight/detail?id=2469462318","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2469462318?lang=en_us&edition=fundamental","pubTime":"2024-09-24 19:30","pubTimestamp":1727177400,"startTime":"0","endTime":"0","summary":"Preclinical proof-of-concept package to be presented at Industry Summit on RASbeing held September 24-26, 2024. NEW YORK and VIENNA, Sept. 24, 2024  -- HOOKIPA Pharma Inc.  , a clinical-stage biopharmaceutical company developing next generation immunotherapeutics for the treatment of cancer and serious infectious diseases, today announced that the Company will present preclinical data related to the HB-700 program for the treatment of KRAS mutated cancers at the 6th Annual RAS-Targeted Drug Development Summit being held in Boston, Massachusetts from September 24-26, 2024.Oral Presentation : Development of an Arenavirus-Based Immunotherapy for Treatment of KRAS Mutant Cancer. Presentation Date/Time: Wednesday, September 25, 12:45 to 1:15 PM ET. Forward Looking StatementsCertain statements set forth in this press release constitute “forward-looking” statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements can be identif","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/Q7WRq3yxOg84DO9NazOLxg--~B/aD00MzI7dz00MzM7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/d51d51e2b4a8372dc9e6035cfa2492f1","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/Q7WRq3yxOg84DO9NazOLxg--~B/aD00MzI7dz00MzM7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/d51d51e2b4a8372dc9e6035cfa2492f1"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/hookipa-pharma-present-strong-preclinical-113000641.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","BK4505","HOOK"],"gpt_icon":0},{"id":"2466423288","title":"Tracking Baker Brothers Portfolio - Q2 2024 Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2466423288","media":"seekingalpha","labels":["analysis"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2466423288?lang=en_us&edition=fundamental","pubTime":"2024-09-11 11:54","pubTimestamp":1726026860,"startTime":"0","endTime":"0","summary":"Baker Brothers' 13F portfolio value decreased from $7.97B to $7.83B this quarter.New stakes include Summit Therapeutics and Alkermes plc, while ACADIA Pharmaceuticals, Madrigal Pharmaceuticals, and In","market":"fut","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1160060870/image_1160060870.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1160060870/image_1160060870.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/article/4720332-tracking-baker-brothers-portfolio-q2-2024-update","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"analysis","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha","symbols":["STOK","ROIV","TCRX","DNLI","KNSA","IGMS","RYTM","CERE","OPT","REPL","BCRX","CERS","ABCL","AKRO","NRIX","ALGS","EWTX","SGMT","HOOK","BCYC","SMMT","IE00BSNM7G36.USD","INSM","IE00B19Z3581.USD","AVTE","GLUE","RVMD","IMCR","KOD","LU0256863902.USD","LU0234570918.USD","MDGL","ATHA","ACHL","TRDA","INCY","ALKS","BGNE","TSVT","ADAP","ARGX","KALA","ACAD","KYMR","VTVT","RARE","BMEA","ABBV","IMTX"],"gpt_icon":1},{"id":"2463734739","title":"HOOKIPA Pharma Names Julie O'Neill Nonexecutive Chair","url":"https://stock-news.laohu8.com/highlight/detail?id=2463734739","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2463734739?lang=en_us&edition=fundamental","pubTime":"2024-08-30 20:32","pubTimestamp":1725021148,"startTime":"0","endTime":"0","summary":"HOOKIPA Pharma (HOOK) said Friday that its board named Director Julie O'Neill nonexecutive chair, succeeding Jan van de Winkel.The company said van de Winkel decided to leave the board because of increasing time commitments from his role as chief executive of Genmab (GMAB).","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","BK4505","HOOK","GMAB"],"gpt_icon":0},{"id":"2463739542","title":"HOOKIPA Pharma Inc - Appoints Julie O’neill as Non-Executive Chair","url":"https://stock-news.laohu8.com/highlight/detail?id=2463739542","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2463739542?lang=en_us&edition=fundamental","pubTime":"2024-08-30 20:00","pubTimestamp":1725019200,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240830:nTUA3WNV8T:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4505","HOOK","BK4139"],"gpt_icon":0},{"id":"2463739525","title":"HOOKIPA Pharma Inc - Tim Reilly Steps Down From HOOKIPA Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2463739525","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2463739525?lang=en_us&edition=fundamental","pubTime":"2024-08-30 20:00","pubTimestamp":1725019200,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240830:nTUA3WNV8T:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4505","HOOK"],"gpt_icon":0},{"id":"2463739320","title":"HOOKIPA Pharma Announces Board of Directors Changes","url":"https://stock-news.laohu8.com/highlight/detail?id=2463739320","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2463739320?lang=en_us&edition=fundamental","pubTime":"2024-08-30 20:00","pubTimestamp":1725019200,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240830:nTUA3WNV8T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4505","HOOK"],"gpt_icon":0},{"id":"2463273931","title":"Press Release: HOOKIPA Pharma Announces Board of Directors Changes","url":"https://stock-news.laohu8.com/highlight/detail?id=2463273931","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2463273931?lang=en_us&edition=fundamental","pubTime":"2024-08-30 20:00","pubTimestamp":1725019200,"startTime":"0","endTime":"0","summary":"NEW YORK and VIENNA, Aug. 30, 2024  -- HOOKIPA Pharma Inc.  , a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, today announced the appointment of Director Julie O'Neill as Non-Executive Chair of the Company's Board of Directors. She succeeds Jan van de Winkel, who has decided to step down from the Board effective August 30, 2024, due to increasing time commitments from his executive position as Chief Executive Officer of Genmab A/S. The Company also announced that Tim Reilly has chosen to step down from the Board, also effective August 30th, to be able to dedicate more time to his other professional responsibilities.\"On behalf of the entire Board, I want to thank Jan for his more than seven years of loyal service and inspirational leadership of the Board of Directors and Tim for his insights and perspectives,\" said Ms. O'Neill. \"We understand their demanding schedules and are grateful for the years of service they provided HOOKIPA. I ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","HOOK","BK4505"],"gpt_icon":0},{"id":"2462018450","title":"HOOKIPA Pharma to Participate in the H.C. Wainwright 26th Annual Global Investment Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2462018450","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2462018450?lang=en_us&edition=fundamental","pubTime":"2024-08-28 20:57","pubTimestamp":1724849820,"startTime":"0","endTime":"0","summary":"NEW YORK and VIENNA, Aug.  28, 2024  (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, “HOOKIPA”, the “Company”), a company developing a new class of immunotherapeutics based on its proprietary a","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/08/28/2937024/0/en/HOOKIPA-Pharma-to-Participate-in-the-H-C-Wainwright-26th-Annual-Global-Investment-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","BK4139","HOOK"],"gpt_icon":0},{"id":"2462048656","title":"Watch Out: 19 Altcoins Have Massive Token Unlocks in the New Week – Here’s the Day-by-Day, Hour-by-Hour List","url":"https://stock-news.laohu8.com/highlight/detail?id=2462048656","media":"CoinMarketCap","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2462048656?lang=en_us&edition=fundamental","pubTime":"2024-08-26 05:14","pubTimestamp":1724620487,"startTime":"0","endTime":"0","summary":"Following the serious rise it experienced this week, the cryptocurrency market will witness a large number of token unlocks in many altcoins in the new week.Here is the token unlock calendar that we, as Bitcoinsistemi.com, have prepared specially for you.Related News: The Two Largest Mining Companies Now Control 56.7 Percent of the Bitcoin Network","market":"us","thumbnail":"https://academy-public.coinmarketcap.com/srd-optimized-uploads/e95458c06dc648c4b9eb5b1c70604857.jpeg","type":0,"news_type":0,"thumbnails":["https://academy-public.coinmarketcap.com/srd-optimized-uploads/e95458c06dc648c4b9eb5b1c70604857.jpeg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://coinmarketcap.com/community/articles/66cb9ec97640b6162a13fdf2/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"coinmarketcap_highlight","symbols":["LU0823426480.USD","OP","AXL","BK4021","BK4535","FET","HOOK","BK4204","LU0455707207.USD","LU2242644610.SGD","BK4124","BK4563","BK4509","BK4510","GT","LU1023057109.AUD","BK4129","LU0327786744.USD","BK4505","LU0370786039.SGD","LU0572944931.SGD","NAVI","LU0359201612.USD","RAD","BK4531","BK4179","BK4119","BK4503","BK4585","LU0502904849.HKD","BK4139","SLND","CHR","BK4506","BK4077","BK4588","BK4166","LU0048580855.USD","LU0823426308.USD","MAV","BK4128","BK4526","LU0359202008.SGD"],"gpt_icon":0},{"id":"2459214463","title":"Top 3 Artificial Intelligence (AI) Coins of the Second Week of August 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2459214463","media":"BE[IN]CRYPTO","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2459214463?lang=en_us&edition=fundamental","pubTime":"2024-08-16 21:00","pubTimestamp":1723813200,"startTime":"0","endTime":"0","summary":"HOOK had the second-biggest rise of 15% after reaching an all-time low this month.Apeiron  price is up by 14% in the last week, attempting to undo the recent 46% crash.The crypto market has experienced a mildly bearish week. Bitcoin and other altcoins, including Artificial Intelligence  tokens, rallied initially but later crashed.BeInCrypto has picked out the best-performing AI tokens in the last seven days, which defeated the bearish market.Leading the Artificial Intelligence token market, ALI emerged as the best-performing asset, noting a rise of 15.48%. Before the altcoin declined in the last three days, ALI was on track to breach the resistance at $0.012.HOOK price, trading at $0.426, marked a near 15% rise in the last seven days. Witnessing a similar fate as ALI, the AI token failed to breach the local resistance of $0.513. This would have pushed the altcoin to breach the critical resistance of $0.600.Read more:How To Invest in Artificial Intelligence  Cryptocurrencies?Read more:T","market":"us","thumbnail":"https://beincrypto.com/wp-content/uploads/2024/02/bic_Artificial-Intelligence_3-covers_neutral-850x478.jpg.optimal.jpg","type":0,"news_type":0,"thumbnails":["https://beincrypto.com/wp-content/uploads/2024/02/bic_Artificial-Intelligence_3-covers_neutral-850x478.jpg.optimal.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://beincrypto.com/top-ai-crypto-second-week-august-2024/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"beincrypto_highlight","symbols":["BK4543","BK4139","BK4554","BK4539","BK4595","HOOK","BK4112","AI","BK4505","BK4585","LU1861558580.USD","BK4588","BK4587","BK4535","BK4023","BK4551","LU1861559042.SGD","BK4528"],"gpt_icon":1},{"id":"2459318351","title":"Analysts Offer Insights on Healthcare Companies: Trevi Therapeutics (TRVI), Replimune Group (REPL) and Hookipa Pharma (HOOK)","url":"https://stock-news.laohu8.com/highlight/detail?id=2459318351","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2459318351?lang=en_us&edition=fundamental","pubTime":"2024-08-13 22:50","pubTimestamp":1723560615,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Trevi Therapeutics (TRVI – Research Report), Replimu...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-trevi-therapeutics-trvi-replimune-group-repl-and-hookipa-pharma-hook?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-trevi-therapeutics-trvi-replimune-group-repl-and-hookipa-pharma-hook?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HCSG","TRVI","REPL","HOOK","BK4139","BK4505","BK4007","BK4137"],"gpt_icon":0},{"id":"2458369987","title":"HOOKIPA Pharma Second Quarter 2024 Earnings: Revenues Miss Expectations","url":"https://stock-news.laohu8.com/highlight/detail?id=2458369987","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2458369987?lang=en_us&edition=fundamental","pubTime":"2024-08-11 20:55","pubTimestamp":1723380910,"startTime":"0","endTime":"0","summary":"NasdaqCM:HOOK Earnings and Revenue Growth August 11th 2024. All figures shown in the chart above are for the trailing 12 month  period. Looking ahead, revenue is forecast to grow 28% p.a. on average during the next 3 years, compared to a 23% growth forecast for the Biotechs industry in the US.The company's shares are down 8.9% from a week ago.It's necessary to consider the ever-present spectre of investment risk.   We've identified 5 warning signs  with HOOKIPA Pharma , and understanding them should be part of your investment process.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/5Vpve0Pc2F3m_L3fs2p_dQ--~B/aD02MzY7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/5Vpve0Pc2F3m_L3fs2p_dQ--~B/aD02MzY7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/hookipa-pharma-second-quarter-2024-125510730.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["HOOK"],"gpt_icon":0},{"id":"2458863634","title":"Can Hooked Protocol (HOOK) Hit a New $35 ATH After 20% Rally?","url":"https://stock-news.laohu8.com/highlight/detail?id=2458863634","media":"CoinMarketCap","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2458863634?lang=en_us&edition=fundamental","pubTime":"2024-08-11 03:04","pubTimestamp":1723316662,"startTime":"0","endTime":"0","summary":"Hooked Protocol (HOOK) is currently attracting plenty of attention in the crypto world after its price went up 20% in just 24 hours. Analysts and investors are once again speculating that the","market":"us","thumbnail":"https://academy-public.coinmarketcap.com/srd-optimized-uploads/9b78609f0bba4f0497ff3cfa226ba998.webp","type":0,"news_type":0,"thumbnails":["https://academy-public.coinmarketcap.com/srd-optimized-uploads/9b78609f0bba4f0497ff3cfa226ba998.webp"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://coinmarketcap.com/community/articles/66b7b9b8d19e583903a91861/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"coinmarketcap_highlight","symbols":["BK4139","BK4505","BTC.USD.HKCC","BTC.USD.CC","ATH","BK4162","HOOK"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.hookipapharma.com","stockEarnings":[{"period":"1week","weight":0.0159},{"period":"1month","weight":-0.0542},{"period":"3month","weight":-0.2558},{"period":"6month","weight":-0.5872},{"period":"1year","weight":-0.107},{"period":"ytd","weight":-0.5259}],"compareEarnings":[{"period":"1week","weight":-0.0138},{"period":"1month","weight":0.0038},{"period":"3month","weight":0.0716},{"period":"6month","weight":0.1169},{"period":"1year","weight":0.3257},{"period":"ytd","weight":0.2014}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase II clinical trial in patients awaiting kidney transplantation from cytomegalovirus-positive donors. Its lead oncology product candidates are HB-201 and HB-202 that are in Phase I/II clinical trial for the treatment of human papillomavirus 16-positive cancers. The company's preclinical stage products include HB-300 program for prostate cancer; and HB-700 for targeting mutated KRAS in pancreatic, colorectal, and lung cancer. HOOKIPA Pharma Inc. has a collaboration with Gilead Sciences, Inc. to collaborate on preclinical research programs to evaluate potential vaccine products using or incorporating its replicating and non-replicating technology platforms for the treatment, cure, diagnosis, or prevention of Hepatitis B Virus. The company was incorporated in 2011 and is headquartered in New York, New York.","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":-0.081948},{"month":2,"riseRate":0.6,"avgChangeRate":0.127152},{"month":3,"riseRate":0.2,"avgChangeRate":-0.060883},{"month":4,"riseRate":0.8,"avgChangeRate":0.068686},{"month":5,"riseRate":0.666667,"avgChangeRate":0.071254},{"month":6,"riseRate":0.166667,"avgChangeRate":-0.206156},{"month":7,"riseRate":0.166667,"avgChangeRate":-0.086653},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.03502},{"month":9,"riseRate":0.166667,"avgChangeRate":-0.08921},{"month":10,"riseRate":0.166667,"avgChangeRate":-0.090753},{"month":11,"riseRate":0.666667,"avgChangeRate":0.047543},{"month":12,"riseRate":0.4,"avgChangeRate":0.014958}],"exchange":"NASDAQ","name":"Hookipa Pharma Inc","nameEN":"Hookipa Pharma Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Hookipa Pharma Inc(HOOK),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Hookipa Pharma Inc(HOOK) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Hookipa Pharma Inc,HOOK,Hookipa Pharma Inc股票,Hookipa Pharma Inc股票老虎,Hookipa Pharma Inc股票老虎国际,Hookipa Pharma Inc行情,Hookipa Pharma Inc股票行情,Hookipa Pharma Inc股价,Hookipa Pharma Inc股市,Hookipa Pharma Inc股票价格,Hookipa Pharma Inc股票交易,Hookipa Pharma Inc股票购买,Hookipa Pharma Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Hookipa Pharma Inc(HOOK),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Hookipa Pharma Inc(HOOK) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction